title: Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
abstract: Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection.
authors.affiliation: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
authors.forename: Renee W Y
authors.initials: RW
authors.lastname: Chan
authors.forename: Michael C W
authors.initials: MC
authors.lastname: Chan
authors.forename: Sudhakar
authors.initials: S
authors.lastname: Agnihothram
authors.forename: Louisa L Y
authors.initials: LL
authors.lastname: Chan
authors.forename: Denise I T
authors.initials: DI
authors.lastname: Kuok
authors.forename: Joanne H M
authors.initials: JH
authors.lastname: Fong
authors.forename: Y
authors.initials: Y
authors.lastname: Guan
authors.forename: Leo L M
authors.initials: LL
authors.lastname: Poon
authors.forename: Ralph S
authors.initials: RS
authors.lastname: Baric
authors.forename: John M
authors.initials: JM
authors.lastname: Nicholls
authors.forename: J S Malik
authors.initials: JS
authors.lastname: Peiris
mesh_terms: D001980:Bronchi / Q000166:cytology / Q000821:virology*; D002460:Cell Line; D017934:Coronavirus / Q000187:drug effects / Q000235:genetics / Q000276:immunology* / Q000502:physiology*; D028941:Coronavirus 229E, Human / Q000502:physiology; D018352:Coronavirus Infections / Q000276:immunology* / Q000821:virology; D004847:Epithelial Cells / Q000821:virology; D006801:Humans; D007113:Immunity, Innate; D007372:Interferons / Q000494:pharmacology; D008168:Lung / Q000166:cytology / Q000821:virology*; D009924:Organ Culture Techniques; D000085064:Receptors, Coronavirus; D011991:Receptors, Virus / Q000378:metabolism; D045473:Severe acute respiratory syndrome-related coronavirus / Q000502:physiology; D045169:Severe Acute Respiratory Syndrome / Q000276:immunology / Q000821:virology; D056189:Viral Tropism; D014779:Virus Replication
chemical_list: D000085064:Receptors, Coronavirus; D011991:Receptors, Virus; D007372:Interferons
references.citation: PLoS Pathog. 2012;8(5):e1002705
references.pmid: 22615565
references.citation: J Virol. 2012 Jan;86(2):1214-26
references.pmid: 22090110
references.citation: J Clin Microbiol. 2006 Jun;44(6):2063-71
references.pmid: 16757599
references.citation: Curr Opin Virol. 2012 Jun;2(3):264-75
references.pmid: 22572391
references.citation: Am J Pathol. 2010 Apr;176(4):1828-40
references.pmid: 20110407
references.citation: Am J Respir Cell Mol Biol. 2013 Jun;48(6):742-8
references.pmid: 23418343
references.citation: Emerg Infect Dis. 2013 Mar;19(3):456-9
references.pmid: 23622767
references.citation: Euro Surveill. 2012 Oct 04;17(40):20290
references.pmid: 23078800
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Virology. 2008 Mar 1;372(1):127-35
references.pmid: 18022664
references.citation: Clin Chem. 2004 Jan;50(1):67-72
references.pmid: 14709637
references.citation: Antiviral Res. 2011 Sep;91(3):330-4
references.pmid: 21798291
references.citation: J Virol. 2005 Dec;79(24):15511-24
references.pmid: 16306622
references.citation: JAMA. 2003 Dec 24;290(24):3222-8
references.pmid: 14693875
references.citation: J Virol. 2011 Nov;85(22):11581-7
references.pmid: 21880750
references.citation: J Infect. 2012 Dec;65(6):477-89
references.pmid: 23072791
references.citation: Lancet. 2002 Dec 7;360(9348):1831-7
references.pmid: 12480361
references.citation: PLoS Med. 2006 Feb;3(2):e27
references.pmid: 16379499
references.citation: Future Virol. 2009 Jan 1;4(1):71-78
references.pmid: 19885368
references.citation: N Engl J Med. 2012 Nov 8;367(19):1814-20
references.pmid: 23075143
references.citation: J Virol. 2005 Jun;79(12):7819-26
references.pmid: 15919935
references.citation: mBio. 2013 Feb 19;4(1):e00611-12
references.pmid: 23422412
references.citation: Lancet. 2003 Jul 26;362(9380):293-4
references.pmid: 12892961
references.citation: Virology. 2004 Nov 10;329(1):11-7
references.pmid: 15476870
references.citation: Antiviral Res. 2011 Jan;89(1):75-82
references.pmid: 21093489
references.citation: Euro Surveill. 2012 Sep 27;17(39):
references.pmid: 23041020
references.citation: PLoS Pathog. 2010 Feb 05;6(2):e1000756
references.pmid: 20140198
references.citation: Blood. 2005 Oct 1;106(7):2366-74
references.pmid: 15860669
references.citation: J Virol. 2007 Jan;81(2):548-57
references.pmid: 17108024
references.citation: Influenza Other Respir Viruses. 2010 Sep;4(5):307-11
references.pmid: 20716159
references.citation: Scand J Infect Dis. 2004;36(11-12):829-31
references.pmid: 15764169
references.citation: mBio. 2012 Nov 20;3(6):
references.pmid: 23170002
references.citation: Nat Med. 2007 Feb;13(2):147-9
references.pmid: 17206149
references.citation: PLoS One. 2010 Nov 10;5(11):e13927
references.pmid: 21085662
references.citation: Virchows Arch. 1994;424(3):295-300
references.pmid: 8186894
references.citation: Euro Surveill. 2012 Sep 27;17(39):
references.pmid: 23041021
references.citation: Nat Med. 2004 Apr;10(4):368-73
references.pmid: 15034574
references.citation: Hong Kong Med J. 2011 Dec;17 Suppl 6:31-5
references.pmid: 22147357
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8091-6
references.pmid: 18523003
references.citation: Virol J. 2013 Feb 28;10:66
references.pmid: 23445530
references.citation: Nat Med. 2004 Mar;10(3):290-3
references.pmid: 14981511
references.citation: J Infect Dis. 2004 Apr 1;189(7):1164-7
references.pmid: 15031783